(Q52913621)
Statements
A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis. (English)
1 reference
Small WC
1 reference
DeSimone-Macchi D
1 reference
Parker JR
1 reference
Sukerkar A
1 reference
Hahn PF
1 reference
Rubin DL
1 reference
Zelch JV
1 reference
Kuhlman JE
1 reference
Outwater EK
1 reference
Weinreb JC
1 reference
Brown JJ
1 reference
de Lange EE
1 reference
Woodward PJ
1 reference
Arildsen R
1 reference
Foster GS
1 reference
Runge VM
1 reference
Aisen AM
1 reference
Muroff LR
1 reference
Thoeni RF
1 reference
Parisky YR
1 reference
Tanenbaum LN
1 reference
Totterman S
1 reference
Herfkens RJ
1 reference
Knudsen J
1 reference
Bernardino ME
1 reference
1 July 1999
1 reference
10
1 reference
1
1 reference
15-24
1 reference